<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Natasha Weeks

18+ years’ experience in the orthopedic industry, specifically trauma and extremities. Previous roles include marketing and product development at JNJ/DePuy Synthes.

Orthopedics

Q120 Trauma Market Growth Halted Mid-March by COVID-19 Pandemic

COVID-19 halts the Trauma Market’s Q120 growth, leading to a -2.8% YoY decline globally. Q120 was tracki...

Orthopedics

Q419/FY19 Trauma Market Recap: Comps & Pricing Pressure Dampens Growth

Tough comps and pricing pressure dampen growth during Q419 According to BioMedGPS’ SmartTRAK Financial D...

Orthobiologics

Q319 Trauma Market Recap: Easy YoY Comparisons Support Sequential Gains

Easy YoY comps along with new product introductions help drive sequential growth SmartTRAK reports that ...

Orthopedics

Q319 Extremities Market Recap: New Products Drive Sequential Growth

New products help drive sequential improvement in growth The WW Market for Foot & Ankle Fixation exc...

Orthopedics

News from AOFAS 2019: Arthrosurface’s New BOSS Toe Fixation System

SmartTRAK Interviews Carl Hasselman, MD about Arthrosurface’s alternative to toe fusions Arthrosurface s...

Orthopedics

Before OTA, Read SmartTRAK's Q219 Trauma Report

Trauma segment experiences slight sequential gains as product intros gain traction and companies overcom...

Orthopedics

SmartTRAK's Q418/FY18 Trauma Market Recap

Sequential improvement despite tough comps, supply disruption and pricing pressure

Orthopedics

Q318 Extremities Market Recap: Increased Pricing Pressure

Extremities Fixation decelerates as shoulder replacements remain strong Q318 WW Extremities Market growt...

Orthopedics

Q318 Trauma Market Recap: Pricing Pressure Impacts Growth

Tough comps, supply disruption and the ever-present pricing pressure impacts growth SmartTRAK reports th...

Orthopedics

Q218 Trauma Market Recap: Healthy Growth, Slight Slowdown

US market experiences slight softening as the top four trauma players all post sequential declines in Q2...